Related Experiment Video
Updated: Sep 28, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
Microangiopathy-related cerebral damage and angiotensinogen gene: from epidemiology to biology
Insights
Microangiopathy-related cerebral damage (MARCD) is linked to specific gene variations in the renin-angiotensin system (RAS). The B haplotype of the angiotensinogen gene promoter was significantly associated with MARCD, independent of hypertension.
Area of Science:
- Genetics
- Neurology
- Cardiovascular Science
Background:
- Microangiopathy-related cerebral damage (MARCD) is prevalent in the elderly, causing cognitive and gait issues.
- Arterial hypertension and age are established risk factors for MARCD.
- Genes regulating blood pressure, particularly the renin-angiotensin system (RAS), are potential candidates for MARCD susceptibility.
Purpose of the Study:
- To investigate the association between angiotensinogen (AGT) gene promoter haplotypes and MARCD.
- To explore the role of local RAS activity in the development of MARCD.
Main Methods:
- Genotyping of four common AGT promoter mutations to define five haplotypes (A, B, C, D, E).
- Association study of AGT haplotypes with MARCD in the Austrian Stroke Prevention Study cohort.
- In vitro investigation of AGT promoter activity in astrocytes.
Main Results:
- The B haplotype of the AGT promoter showed a significant association with MARCD (p = 0.005).
- This association remained significant even after accounting for hypertension, suggesting a direct genetic link.
- Promoter activity assays indicated that AGT gene expression can be modulated by specific haplotypes.
Conclusions:
- Specific haplotypes of the angiotensinogen gene promoter are associated with microangiopathy-related cerebral damage.
- The findings suggest a potential role for the local renin-angiotensin system in the pathogenesis of MARCD, independent of systemic blood pressure regulation.
- Genetic variations in the AGT gene may contribute to cerebral microvascular disease susceptibility.
Abstract:
Microangiopathy-related cerebral damage (MARCD) is a common finding in the elderly. It may lead to cognitive impairment and gait disturbances. Arterial hypertension and age are the best accepted risk factors for MARCD. Genes involved in blood pressure regulation, like genes encoding the proteins of the renin-angiotensin system (RAS) therefore represents good candidate genes for MARCD. Plasma angiotensinogen level is a major determinant of the RAS activity. Positive correlation between angiotensinogen gene expression and RAS activity, as well as blood pressure were observed. Common mutations described in the AGT promoter were able to alter AGT expression in cell culture. We described that 4 frequent mutations at the AGT promoter are combined in 5 haplotypes coded as A (-6:g, -20:a, -152:g, -217:g), B (-6:a, -20:c, -152:g, -217:g), C (-6:a, -20:c, -152:a, -217:g), D (-6:a, -20:a, -152:g, -217:g), and E (-6:a, -20:a, -152:g, -217:a). The B haplotype was significantly associated with MARCD in the cohort of the Austrian Stroke Prevention Study (p = 0.005). The association was independent of hypertension, which pinpointed to a possible role of the local RAS in this relationship. Investigation of the promoter activity of the AGT gene in astrocytes suggests that expression of this gene may be modulated by the haplotype.
Related Concept Videos
Mechanism of Angiogenesis
Diabetic Nephropathy
Coronary Artery Disease I: Introduction
Diabetic Retinopathy
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
